Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Nele Brusselaers, Andreas Vall, Fredrik Mattsson & Jesper Lagergren. (2015) Tumour staging of oesophageal cancer in the Swedish Cancer Registry: A nationwide validation study. Acta Oncologica 54:6, pages 903-908.
Read now
Read now
Eva Hagel, Hans Garmo, Anna Bill-Axelson, Ola Bratt, Jan-Erik Johansson, Jan Adolfsson, Mats Lambe & Pär Stattin. (2009) PCBaSe Sweden: A register-based resource for prostate cancer research. Scandinavian Journal of Urology and Nephrology 43:5, pages 342-349.
Read now
Read now
Jan Adolfsson, Hans Garmo, Eberhard Varenhorst, Göran Ahlgren, Christer Ahlstrand, Ove Andrén, Anna Bill-Axelson, Ola Bratt, Jan-Erik Damber, Karin Hellström, Magnus Hellström, Erik Holmberg, Lars Holmberg, Jonas Hugosson, Jan-Erik Johansson, Bill Petterson, Magnus Törnblom, Anders Widmark & Pär Stattin. (2007) Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scandinavian Journal of Urology and Nephrology 41:6, pages 456-477.
Read now
Read now
David Robinson, Gunnar Aus, Julia Bak, Tomasz Gorecki, Anders Herder, Johan Rosell & Eberhard Varenhorst. (2007) Long-term follow-up of conservatively managed incidental carcinoma of the prostate A multivariate analysis of prognostic factors. Scandinavian Journal of Urology and Nephrology 41:2, pages 103-109.
Read now
Read now
Eberhard Varenhorst, Hans Garmo, Lars Holmberg, Jan Adolfsson, Jan-Erik Damber, Magnus Hellström, Jonas Hugosson, Rolf Lundgren, Pär Stattin, Magnus Törnblom & Jan-Erik Johansson. (2005) The National Prostate Cancer Register in Sweden 1998—2002: Trends in incidence, treatment and survival. Scandinavian Journal of Urology and Nephrology 39:2, pages 117-123.
Read now
Read now
Karin Sennfält, Per Carlsson, Gabriel Sandblom & Eberhard Varenhorst. (2004) The estimated economic value of the welfare loss due to prostate cancer pain in a defined population. Acta Oncologica 43:3, pages 290-296.
Read now
Read now
Karin Sennfält, Gabriel Sandblom, Per Carlsson & Eberhard Varenhorst. (2004) Costs and effects of prostate cancer screening in SwedenA 15-year follow-up of a randomized trial. Scandinavian Journal of Urology and Nephrology 38:4, pages 291-298.
Read now
Read now
Articles from other publishers (28)
Weiqiang Li, Mridu Middha, Mesude Bicak, Daniel D. Sjoberg, Emily Vertosick, Anders Dahlin, Christel Häggström, Göran Hallmans, Ann-Charlotte Rönn, Pär Stattin, Olle Melander, David Ulmert, Hans Lilja & Robert J. Klein. (2018) Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival. European Urology 74:6, pages 710-719.
Crossref
Crossref
Peter Wallström, Isabel Drake, Emily Sonestedt, Bo Gullberg, Anders Bjartell, Håkan Olsson, Herman Adlercreutz, Matti J. Tikkanen & Elisabet Wirfält. (2017) Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men. European Journal of Nutrition 57:7, pages 2595-2606.
Crossref
Crossref
Daniel D. Sjoberg, Andrew J. Vickers, Melissa Assel, Anders Dahlin, Bing Ying Poon, David Ulmert & Hans Lilja. (2018) Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men. European Urology 73:6, pages 941-948.
Crossref
Crossref
Daniel Carlzon, Johan Svensson, Max Petzold, Magnus K. Karlsson, Östen Ljunggren, Mohammad-Ali Haghsheno, Jan-Erik Damber, Dan Mellström & Claes Ohlsson. (2016) Insulin-like growth factor I and risk of incident cancer in elderly men - results from MrOS (Osteoporotic Fractures in Men) in Sweden. Clinical Endocrinology 84:5, pages 764-770.
Crossref
Crossref
Rami Klaff, Johan Rosell, Eberhard Varenhorst & Gabriel Sandblom. (2016) The Long-term Disease-specific Mortality of Low-risk Localized Prostate Cancer: A Prospective Population-based Register Study Over Two Decades. Urology 91, pages 77-82.
Crossref
Crossref
Tanja Stocks, Tone Bjørge, Hanno Ulmer, Jonas Manjer, Christel Häggström, Gabriele Nagel, Anders Engeland, Dorthe Johansen, Göran Hallmans, Randi Selmer, Hans Concin, Steinar Tretli, Håkan Jonsson & Pär Stattin. (2015) Metabolic risk score and cancer risk: pooled analysis of seven cohorts. International Journal of Epidemiology 44:4, pages 1353-1363.
Crossref
Crossref
Katarina Tomic, Fredrik Sandin, Annette Wigertz, David Robinson, Mats Lambe & Pär Stattin. (2015) Evaluation of data quality in the National Prostate Cancer Register of Sweden. European Journal of Cancer 51:1, pages 101-111.
Crossref
Crossref
Christel Häggström, Tanja Stocks, Gabriele Nagel, Jonas Manjer, Tone Bjørge, Göran Hallmans, Anders Engeland, Hanno Ulmer, Björn Lindkvist, Randi Selmer, Hans Concin, Steinar Tretli, Håkan Jonsson & Pär Stattin. (2014) Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations. Epidemiology 25:6, pages 823-828.
Crossref
Crossref
Isabel Drake, Peter Wallström, George Hindy, Ulrika Ericson, Bo Gullberg, Anders Bjartell, Emily Sonestedt, Marju Orho-Melander & Elisabet Wirfält. (2014)
TCF7L2
type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer
. The Prostate 74:12, pages 1161-1170.
Crossref
Crossref
Isabel Drake, Emily Sonestedt, Bo Gullberg, Anders Bjartell, Håkan Olsson, Herman Adlercreutz, Matti J. Tikkanen, Elisabet Wirfält & Peter Wallström. (2014) Plasma Alkylresorcinol Metabolites as Biomarkers for Whole-Grain Intake and Their Association with Prostate Cancer: A Swedish Nested Case–Control Study. Cancer Epidemiology, Biomarkers & Prevention 23:1, pages 73-83.
Crossref
Crossref
M. Van Hemelrijck, A. Wigertz, F. Sandin, H. Garmo, K. Hellstrom, P. Fransson, A. Widmark, M. Lambe, J. Adolfsson, E. Varenhorst, J.-E. Johansson, P. Stattin, L. Drevin, A. Bill-Axelson, D. Robinson & O. Akre. (2012) Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. International Journal of Epidemiology 42:4, pages 956-967.
Crossref
Crossref
Christel Häggström, Kilian Rapp, Tanja Stocks, Jonas Manjer, Tone Bjørge, Hanno Ulmer, Anders Engeland, Martin Almqvist, Hans Concin, Randi Selmer, Börje Ljungberg, Steinar Tretli, Gabriele Nagel, Göran Hallmans, Håkan Jonsson & Pär Stattin. (2013) Metabolic Factors Associated with Risk of Renal Cell Carcinoma. PLoS ONE 8:2, pages e57475.
Crossref
Crossref
Christel Häggström, Tanja Stocks, David Ulmert, Tone Bjørge, Hanno Ulmer, Göran Hallmans, Jonas Manjer, Anders Engeland, Gabriele Nagel, Martin Almqvist, Randi Selmer, Hans Concin, Steinar Tretli, Håkan Jonsson & Pär Stattin. (2012) Prospective study on metabolic factors and risk of prostate cancer. Cancer 118:24, pages 6199-6206.
Crossref
Crossref
Isabel Drake, Emily Sonestedt, Bo Gullberg, Göran Ahlgren, Anders Bjartell, Peter Wallström & Elisabet Wirfält. (2012) Dietary intakes of carbohydrates in relation to prostate cancer risk: a prospective study in the Malmö Diet and Cancer cohort. The American Journal of Clinical Nutrition 96:6, pages 1409-1418.
Crossref
Crossref
Sze Ting Lee, Nathan Lawrentschuk & Andrew M. Scott. (2012) PET in Prostate and Bladder Tumors. Seminars in Nuclear Medicine 42:4, pages 231-246.
Crossref
Crossref
Kristin Gunderson, Christopher Y. Wang & Ruoxiang Wang. (2011) Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans. Cancer Epidemiology 35:4, pages 320-327.
Crossref
Crossref
Christel Häggström, Tanja Stocks, Kilian Rapp, Tone Bjørge, Björn Lindkvist, Hans Concin, Anders Engeland, Jonas Manjer, Hanno Ulmer, Randi Selmer, Steinar Tretli, Göran Hallmans, Håkan Jonsson & Pär Stattin. (2011) Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me‐Can). International Journal of Cancer 128:8, pages 1890-1898.
Crossref
Crossref
Hans Lilja, Angel M. Cronin, Anders Dahlin, Jonas Manjer, Peter M. Nilsson, James A. Eastham, Anders S. Bjartell, Peter T. Scardino, David Ulmert & Andrew J. Vickers. (2010) Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50. Cancer 117:6, pages 1210-1219.
Crossref
Crossref
ANGELA C WEBSTER, RAJAH SUPRAMANIAM, DIANNE L O'CONNELL, JEREMY R CHAPMAN & JONATHAN C CRAIG. (2010) Validity of registry data: Agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Nephrology 15:4, pages 491-501.
Crossref
Crossref
Sam Ladjevardi, Gabriel Sandblom, Anders Berglund & Eberhard Varenhorst. (2010) Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer. European Urology 57:4, pages 631-640.
Crossref
Crossref
P Wallström, A Bjartell, B Gullberg, H Olsson & E Wirfält. (2009) A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. British Journal of Cancer 100:11, pages 1799-1805.
Crossref
Crossref
A Andersson, G Enblad, B Tavelin, M Björkholm, J Linderoth, I Lagerlöf, M Merup, M Sender & B Malmer. (2008) Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma. British Journal of Cancer 98:5, pages 1001-1005.
Crossref
Crossref
Peter Wallström, Anders Bjartell, Bo Gullberg, Håkan Olsson & Elisabet Wirfält. (2007) A prospective study on dietary fat and incidence of prostate cancer (Malmö, Sweden). Cancer Causes & Control 18:10, pages 1107-1121.
Crossref
Crossref
Maria Hedelin, Ellen T. Chang, Fredrik Wiklund, Rino Bellocco, Åsa Klint, Jan Adolfsson, Katarina Shahedi, Jianfeng Xu, Hans-Olov Adami, Henrik Grönberg & Katarina Augustsson Bälter. (2007) Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. International Journal of Cancer 120:2, pages 398-405.
Crossref
Crossref
Karin Sennfält, Per Carlsson & Eberhard Varenhorst. (2006) Diffusion and Economic Consequences of Health Technologies in Prostate Cancer Care in Sweden, 1991–2002. European Urology 49:6, pages 1028-1034.
Crossref
Crossref
Gunnar Aus, David Robinson, Johan Rosell, Gabriel Sandblom & Eberhard Varenhorst. (2005) Survival in prostate carcinoma—Outcomes from a prospective, population‐based cohort of 8887 men with up to 15 years of follow‐up. Cancer 103:5, pages 943-951.
Crossref
Crossref
Gabriel Sandblom, Eberhard Varenhorst, Owe Löfman, Johan Rosell & Per Carlsson. (2004) Clinical Consequences of Screening for Prostate Cancer: 15 Years Follow-up of a Randomised Controlled Trial in Sweden. European Urology 46:6, pages 717-724.
Crossref
Crossref
G Sandblom, P Carlsson, K Sennfält & E Varenhorst. (2004) A population-based study of pain and quality of life during the year before death in men with prostate cancer. British Journal of Cancer 90:6, pages 1163-1168.
Crossref
Crossref